SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 260 filers reported holding SAGE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $755,658 | -26.1% | 16,071 | -34.0% | 0.01% | -16.7% |
| Q1 2023 | $1,021,852 | +31.4% | 24,353 | +19.5% | 0.01% | +20.0% |
| Q4 2022 | $777,446 | -31.1% | 20,384 | -29.3% | 0.01% | -16.7% |
| Q3 2022 | $1,129,000 | -56.8% | 28,834 | -64.4% | 0.01% | -62.5% |
| Q2 2022 | $2,614,000 | +28.5% | 80,923 | +31.6% | 0.02% | -5.9% |
| Q1 2022 | $2,035,000 | -52.7% | 61,470 | -39.3% | 0.02% | -58.5% |
| Q4 2021 | $4,306,000 | -13.5% | 101,230 | -9.9% | 0.04% | -34.9% |
| Q3 2021 | $4,979,000 | +171.0% | 112,376 | +247.5% | 0.06% | +200.0% |
| Q2 2021 | $1,837,000 | +5.6% | 32,340 | +39.1% | 0.02% | -4.5% |
| Q1 2021 | $1,740,000 | -31.3% | 23,250 | -43.9% | 0.02% | -42.1% |
| Q3 2020 | $2,534,000 | +58.4% | 41,459 | +7.7% | 0.04% | +35.7% |
| Q2 2020 | $1,600,000 | -30.3% | 38,479 | -51.9% | 0.03% | -54.8% |
| Q1 2020 | $2,297,000 | -56.2% | 79,986 | +10.1% | 0.06% | -35.4% |
| Q4 2019 | $5,243,000 | +1020.3% | 72,624 | +2075.7% | 0.10% | +966.7% |
| Q3 2019 | $468,000 | -8.2% | 3,338 | +19.9% | 0.01% | 0.0% |
| Q2 2019 | $510,000 | -57.1% | 2,785 | -62.8% | 0.01% | -76.9% |
| Q1 2019 | $1,190,000 | +107.3% | 7,479 | +24.7% | 0.04% | +44.4% |
| Q4 2018 | $574,000 | -65.3% | 5,996 | -48.9% | 0.03% | -70.0% |
| Q3 2018 | $1,656,000 | -86.1% | 11,727 | -84.6% | 0.09% | -84.9% |
| Q2 2018 | $11,913,000 | +20439.7% | 76,110 | +21645.7% | 0.60% | +19833.3% |
| Q4 2017 | $58,000 | -12.1% | 350 | -66.7% | 0.00% | -25.0% |
| Q3 2017 | $66,000 | -73.0% | 1,052 | -65.6% | 0.00% | -75.0% |
| Q2 2017 | $244,000 | +115.9% | 3,058 | +91.8% | 0.02% | +100.0% |
| Q1 2017 | $113,000 | -8.1% | 1,594 | -34.1% | 0.01% | -20.0% |
| Q4 2016 | $123,000 | -19.1% | 2,418 | -26.9% | 0.01% | 0.0% |
| Q3 2016 | $152,000 | +15100.0% | 3,306 | +7246.7% | 0.01% | – |
| Q2 2016 | $1,000 | -99.9% | 45 | -99.8% | 0.00% | -100.0% |
| Q1 2016 | $802,000 | +206.1% | 25,023 | +304.1% | 0.05% | +253.8% |
| Q3 2015 | $262,000 | +20.7% | 6,192 | -10.2% | 0.01% | 0.0% |
| Q3 2014 | $217,000 | – | 6,895 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
| Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
| Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
| Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
| PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
| EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
| Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
| Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
| SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
| CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |